|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02659 BAO PHARMA-B
Nominal 
() | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | |
| Turnover | 6,160 | -11.111% | 6,930 |
| Cost of Sales | (1,140) | 665.101% | (149) |
| Gross Profit | 5,020 | -25.970% | 6,781 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | (5,566) | -- | -- | |
| Share of Results of Asso. & JCEs | (609) | -33.443% | (915) | |
| Profit / (Loss) before Taxation | (364,456) | 127.223% | (160,396) | |
| Taxation | 23 | 2200.000% | 1 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (364,433) | 127.210% | (160,395) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (90) | -97.878% | (4,241) |
| Depreciation & Amortisation | 32,136 | 43.247% | 22,434 |
| Directors' Emoluments | 101,861 | 2403.958% | 4,068 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | |
| EPS (cts) | -681.000 | 114.826% | -317.000 |
| DPS (cts) | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | (4.105) | -- | (2.771) |
| NBV per share ($) | -- | -- | -- |
| Remarks: | Real time quote last updated: 04/12/2025 09:09 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -183,096 |
| %Change | 9.449% |
| EPS / (LPS) | RMB -3.180 |
| NBV Per Share (¥) | RMB -- |